Circulating cell-free mitochondrial DNA as a diagnostic and prognostic biomarker in chronic and late acute graft-versus-host disease in children
Experimental Hematology · 2023
DOI: 10.1016/j.exphem.2023.02.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Hematology, 2023. Verfasst von Shima Azadpour und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. Hauptthemen laut MEDLINE: DNA, Mitochondrial, Graft vs Host Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: CIHR ICR.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
In an earlier study, we found that mitochondrial DNA (mtDNA) concentration is elevated in adults with chronic graft-versus-host disease (cGvHD), acting as an endogenous source of TLR9 agonists to augment B-cell responses. To validate this in children, we evaluated mtDNA plasma expression in a large pediatric cohort (ABLE/PBMTC 1202 study). Plasma cell-free mtDNA (cf-mtDNA) copy numbers were measured in 202 pediatric patients using quantitative Droplet Digital polymerase chain reaction (ddPCR). Two evaluations were performed: 1) before the onset of cGvHD or late acute graft-versus-host disease (aGvHD) at day 100 ± 14 days and 2) at the time of cGvHD onset compared with time-matched non-cGvHD controls. We found that cf-mtDNA copy numbers were not affected by immune reconstitution post-hematopoietic stem cell transplantation but were higher on day 100 before the onset of late aGvHD and at the onset of cGvHD. We found that cf-mtDNA was not impacted by previous aGvHD, but correlated with the early onset, NIH moderate/severe cGvHD, and did not correlate with other immune cell populations, cytokines, or chemokines but did with the metabolites spermine and taurine. Similar to adults, children have elevated plasma cf-mtDNA concentrations at the early onset of cGvHD, especially in NIH moderate/severe cGvHD, elevation with late aGvHD, and associated with metabolites involved in mitochondrial function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Haematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
- Michael Cuccione Childhood Cancer Research Program, British Columbia Children's Hospital Research Institute, University of British Columbia, Vancouver, BC, Canada.
- Department of Statistics, Centre for Molecular Medicine and Therapeutics, British Columbia Children's Hospital, University of British Columbia, Vancouver, BC, Canada.
- Pediatric Blood and Marrow Transplantation, CancerCare Manitoba, University of Manitoba, Winnipeg, MB, Canada.
- Michael Cuccione Childhood Cancer Research Program, British Columbia Children's Hospital Research Institute, University of British Columbia, Vancouver, BC, Canada. Electronic address: kschultz@mail.ubc.ca.
Förderung
- CIHR ICR
Zitieren
APA
Azadpour, S., Abdossamadi, S., Ng, B., Ostroumov, E., Abroun, S., Cuvelier, G. D. E., & Schultz, K. R. (2023). Circulating cell-free mitochondrial DNA as a diagnostic and prognostic biomarker in chronic and late acute graft-versus-host disease in children. Experimental Hematology. https://doi.org/10.1016/j.exphem.2023.02.004
Vancouver
Azadpour S, Abdossamadi S, Ng B, Ostroumov E, Abroun S, Cuvelier GDE, et al. Circulating cell-free mitochondrial DNA as a diagnostic and prognostic biomarker in chronic and late acute graft-versus-host disease in children. Experimental Hematology. 2023. doi:10.1016/j.exphem.2023.02.004
BibTeX
@article{Azadpour2023,
author = {Azadpour, Shima and Abdossamadi, Sayeh and Ng, Bernard and Ostroumov, Elena and Abroun, Saeid and Cuvelier, Geoffrey D E and Schultz, Kirk R},
title = {Circulating cell-free mitochondrial DNA as a diagnostic and prognostic biomarker in chronic and late acute graft-versus-host disease in children},
journal = {Experimental Hematology},
year = {2023},
doi = {10.1016/j.exphem.2023.02.004}
}
EUVIMED